Sangwook Oh

Assistant Professor

Hallym University

South Korea

Research Interests

Explore related searches

Professors in South Korea Professors in Immunology Immunology professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Sangwook Oh is an Assistant Professor at Hallym University in South Korea. His research primarily focuses on myasthenia gravis, particularly in the areas of antibody-mediated mechanisms and precision B cell targeting therapies. He has published extensively on topics such as chimeric autoantibody receptor T cells and innovative cellular therapies for autoimmune diseases.

Articles (9)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2020

Year:

2020

Collaborators (5)

Samik Basu

Chief Scientific Officer

Cabaletta Bio

UNITED STATES

View details

James Howard

Professor

University of North Carolina at Chapel Hill

UNITED STATES

View details

Aimee S. Payne

University of Pennsylvania

UNITED STATES

View details

Christoph Ellebrecht

Hospital of the University of Pennsylvania

UNITED STATES

View details

Kevin O'Connor

Associate Professor

Yale University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sangwook Oh

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Composition and function of AChR chimeric autoantibody receptor T cells for antigen-specific B cell depletion in myasthenia gravis

Author Correction: Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells

Clinicoserological insights into patients with immune checkpoint inhibitor‐induced myasthenia gravis

Individual myasthenia gravis autoantibody clones can efficiently mediate multiple mechanisms of pathology

Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells.

MuSK-CAART: A novel precision cellular therapy for muscle-specific tyrosine kinase myasthenia gravis

Engineering Cell Therapies for Autoimmune Diseases: From Preclinical to Clinical Proof of Concept

Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgaris

Twist2 promotes CD8<sup>+</sup> T-cell differentiation by repressing ThPOK expression

Collaborators (5)

Samik Basu

James Howard

Aimee S. Payne

Christoph Ellebrecht

Kevin O'Connor

Make your next move.